Sartorius (SARTF) Projected to Post Earnings on Thursday
by Doug Wharley · The Cerbat GemSartorius (OTCMKTS:SARTF – Get Free Report) will likely be posting its resultson Thursday, April 23rd. Analysts expect Sartorius to post earnings of $1.37 per share and revenue of $932.2810 million for the quarter.
Sartorius Price Performance
SARTF stock opened at $226.33 on Tuesday. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49. The firm has a market capitalization of $7.75 billion, a P/E ratio of 105.27 and a beta of 0.98. The business’s 50-day moving average is $226.33 and its two-hundred day moving average is $219.72. Sartorius has a 1 year low of $165.00 and a 1 year high of $226.33.
Sartorius Company Profile
Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.